An important cause of pulmonary arterial hypertension (PAH) in children with congenital heart disease (CHD) is increased pulmonary blood flow (PBF). To gain a better understanding of the disease process, the changes in biochemical pathways and metabolism of pulmonary arterial smooth muscle cells (PASMCs) were studied using a unique surgical ovine model of increased pulmonary blood flow. PASMCs isolated from 4-week-old lambs with increased PBF (shunt) showed lower oxygen consumption rates and lower extracellular acidification rates linked to glutamine metabolism when compared to controls. Shunt and control PASMCs both exhibited a switch into the reverse tricarboxylic acid (TCA) cycle, while only shunt cells showed a decrease of glucose being...
Pulmonary arterial hypertension (PAH) is a progressive disease of the lung vasculature that involves...
Pulmonary arterial hypertension (PAH) is characterized by remodeling and narrowing of the pulmonary ...
In this article, we review the current state of knowledgeabout early changes in the pulmonary vascul...
An important cause of pulmonary arterial hypertension (PAH) in children with congenital heart diseas...
The risk and progression of pulmonary vascular disease in patients with congenital heart disease is ...
The high morbidity and mortality rate of pulmonary arterial hypertension (PAH) is partially explaine...
BackgroundMitochondrial reactive oxygen species (ROS) levels and nuclear factor kappa-light-chain-en...
Hypoxia, namely a lack of oxygen in the blood, induces pulmonary vasoconstriction and vasoremodeling...
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vasoproliferative disorder characte...
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vasoproliferative disorder characte...
Pulmonary hypertension (PH) is one of the most devastating cardiovascular diseases worldwide and it ...
Background: Platelet activating factor (PAF) is a phospholipid synthesized by the action of phosphol...
Altered metabolism in pulmonary artery smooth muscle cells (PASMCs) and endothelial cells (PAECs) co...
Changes in reactive oxygen species and extracellular matrix seem to participate in pulmonary hyperte...
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by elevated pulmonary a...
Pulmonary arterial hypertension (PAH) is a progressive disease of the lung vasculature that involves...
Pulmonary arterial hypertension (PAH) is characterized by remodeling and narrowing of the pulmonary ...
In this article, we review the current state of knowledgeabout early changes in the pulmonary vascul...
An important cause of pulmonary arterial hypertension (PAH) in children with congenital heart diseas...
The risk and progression of pulmonary vascular disease in patients with congenital heart disease is ...
The high morbidity and mortality rate of pulmonary arterial hypertension (PAH) is partially explaine...
BackgroundMitochondrial reactive oxygen species (ROS) levels and nuclear factor kappa-light-chain-en...
Hypoxia, namely a lack of oxygen in the blood, induces pulmonary vasoconstriction and vasoremodeling...
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vasoproliferative disorder characte...
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vasoproliferative disorder characte...
Pulmonary hypertension (PH) is one of the most devastating cardiovascular diseases worldwide and it ...
Background: Platelet activating factor (PAF) is a phospholipid synthesized by the action of phosphol...
Altered metabolism in pulmonary artery smooth muscle cells (PASMCs) and endothelial cells (PAECs) co...
Changes in reactive oxygen species and extracellular matrix seem to participate in pulmonary hyperte...
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by elevated pulmonary a...
Pulmonary arterial hypertension (PAH) is a progressive disease of the lung vasculature that involves...
Pulmonary arterial hypertension (PAH) is characterized by remodeling and narrowing of the pulmonary ...
In this article, we review the current state of knowledgeabout early changes in the pulmonary vascul...